Omeprazole Sulfone (CAS 88546-55-8)
See product citations (2)
QUICK LINKS
Omeprazole sulfone serves as an organic compound of significance, particularly as an intermediate in the synthesis of the widely used proton pump inhibitor, omeprazole. It represents a sulfonamide derivative derived from the benzimidazole nucleus, playing a pivotal role as a key intermediate for the synthesis of omeprazole and its analogues. Notably, omeprazole sulfone acts as an intermediary during the production process of the proton pump inhibitor omeprazole. As a proton pump inhibitor, omeprazole functions by inhibiting the activity of the H+/K+-ATPase enzyme responsible for gastric acid production. By impeding the function of this enzyme, omeprazole effectively diminishes the secretion of gastric acid, resulting in a reduction in the overall acidity of stomach contents.
Omeprazole Sulfone (CAS 88546-55-8) References
- Assay of omeprazole and omeprazole sulfone by semi-microcolumn liquid chromatography with mixed-function precolumn. | Yim, DS., et al. 2001. J Chromatogr B Biomed Sci Appl. 754: 487-93. PMID: 11339292
- CYP2C19- and CYP3A4-dependent omeprazole metabolism in West Mexicans. | Gonzalez, HM., et al. 2003. J Clin Pharmacol. 43: 1211-5. PMID: 14551175
- Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population. | Sohn, DR., et al. 1992. J Pharmacol Exp Ther. 262: 1195-202. PMID: 1527724
- Determination of omeprazole, hydroxyomeprazole and omeprazole sulfone using automated solid phase extraction and micellar electrokinetic capillary chromatography. | Pérez-Ruiz, T., et al. 2006. J Pharm Biomed Anal. 42: 100-6. PMID: 16280228
- Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry. | Hofmann, U., et al. 2006. J Chromatogr B Analyt Technol Biomed Life Sci. 831: 85-90. PMID: 16338182
- Use of omeprazole sulfone in a single plasma sample as a probe for CYP3A4. | Böttiger, Y. 2006. Eur J Clin Pharmacol. 62: 621-5. PMID: 16791583
- Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19 PMs. | Sugimoto, K., et al. 2008. Eur J Clin Pharmacol. 64: 583-7. PMID: 18214455
- The (R)-omeprazole hydroxylation index reflects CYP2C19 activity in healthy Japanese volunteers. | Yamada, S., et al. 2013. Eur J Clin Pharmacol. 69: 1423-8. PMID: 23435615
- Inhibition of CYP2C19 and CYP3A4 by omeprazole metabolites and their contribution to drug-drug interactions. | Shirasaka, Y., et al. 2013. Drug Metab Dispos. 41: 1414-24. PMID: 23620487
- Stereoselective Metabolism of Omeprazole by Cytochrome P450 2C19 and 3A4: Mechanistic Insights from DFT Study. | Jana, K., et al. 2018. J Phys Chem B. 122: 5765-5775. PMID: 29741901
- Effects of elagolix on the pharmacokinetics of omeprazole and its metabolites in healthy premenopausal women. | Nader, A., et al. 2022. Clin Transl Sci. 15: 1269-1280. PMID: 35137535
- Inhibition of the sulfoxidation of omeprazole by ketoconazole in poor and extensive metabolizers of S-mephenytoin. | Böttiger, Y., et al. 1997. Clin Pharmacol Ther. 62: 384-91. PMID: 9357389
- Artemisinin induces omeprazole metabolism in human beings. | Svensson, US., et al. 1998. Clin Pharmacol Ther. 64: 160-7. PMID: 9728896
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Omeprazole Sulfone, 10 mg | sc-212477 | 10 mg | $352.00 |